Matches in SemOpenAlex for { <https://semopenalex.org/work/W2060984942> ?p ?o ?g. }
- W2060984942 endingPage "854" @default.
- W2060984942 startingPage "831" @default.
- W2060984942 abstract "Recently approved therapies for treatment of relapsing-remitting multiple sclerosis (MS) include interferon β1b (IFNβ1b) (Betaseron®), IFNβ1a (Avonex®) and co-polymer-1 (Copaxone®). These drugs modulate the immune response and curtail the apparent autoimmunity to antigens present in the central nervous system (CNS). New therapies for MS seek to promote more lasting recovery from the impairment of neurologic function in addition to decreasing the ongoing damage to the CNS. Prominent pathologic features of MS include inflammation, demyelination and axonal damage in the CNS. Identification of effector molecules linked with the emergence of these neuropathologic features and clinical signs of disease is a hot area of research. Preclinical research for therapeutics for MS has focused on compounds with increased specificity for an array of targets that include released factors (cytokines), cell surface molecules (T-cell receptors, co-stimulatory molecules, matrix metalloproteinases [MMPs]), intracellular enzymes in signalling cascades (phosphodiesterase [PDE], nitric oxide synthase [NOS]), and regulatory molecules involved in programmed cell death pathways or regulation of gene expression. Our increased understanding of immune regulation, oligodendrocyte biology and pathogenic events in MS has expanded the spectrum of potential targets for drug development in MS, ranging from activation of autoreactive T-cells through the cascade of events that ultimately leads to demyelination, loss of axons and permanent clinical disability. Moreover, rapidly advancing techniques in neuroimaging may allow earlier predictions of efficacy by monitoring the integrity of myelin and neurones. This review summarises recent progress in the preclinical drug development for MS, including therapeutic agents that modulate neural and immune system interactions, cytokine production, T-cell phenotypes, lymphocyte migration and oligodendrocyte survival." @default.
- W2060984942 created "2016-06-24" @default.
- W2060984942 creator A5013642487 @default.
- W2060984942 date "1998-07-01" @default.
- W2060984942 modified "2023-09-25" @default.
- W2060984942 title "Recent advances in preclinical drug development in multiple sclerosis" @default.
- W2060984942 cites W1492606093 @default.
- W2060984942 cites W1799419079 @default.
- W2060984942 cites W1866034006 @default.
- W2060984942 cites W1888783223 @default.
- W2060984942 cites W1899554279 @default.
- W2060984942 cites W1969198078 @default.
- W2060984942 cites W1970124662 @default.
- W2060984942 cites W1971545951 @default.
- W2060984942 cites W1972742027 @default.
- W2060984942 cites W1973290618 @default.
- W2060984942 cites W1974967725 @default.
- W2060984942 cites W1980848387 @default.
- W2060984942 cites W1982005094 @default.
- W2060984942 cites W1982476760 @default.
- W2060984942 cites W1986049298 @default.
- W2060984942 cites W1993231756 @default.
- W2060984942 cites W1995082592 @default.
- W2060984942 cites W1995441076 @default.
- W2060984942 cites W1996353122 @default.
- W2060984942 cites W2003073828 @default.
- W2060984942 cites W2007840608 @default.
- W2060984942 cites W2008120575 @default.
- W2060984942 cites W2011056756 @default.
- W2060984942 cites W2011730327 @default.
- W2060984942 cites W2012739094 @default.
- W2060984942 cites W2013377378 @default.
- W2060984942 cites W2014323783 @default.
- W2060984942 cites W2014954180 @default.
- W2060984942 cites W2019899829 @default.
- W2060984942 cites W2022853021 @default.
- W2060984942 cites W2025009691 @default.
- W2060984942 cites W2026467573 @default.
- W2060984942 cites W2032743208 @default.
- W2060984942 cites W2034751393 @default.
- W2060984942 cites W2036842448 @default.
- W2060984942 cites W2038052320 @default.
- W2060984942 cites W2041897519 @default.
- W2060984942 cites W2045403629 @default.
- W2060984942 cites W2050382167 @default.
- W2060984942 cites W2051123512 @default.
- W2060984942 cites W2057335255 @default.
- W2060984942 cites W2058119565 @default.
- W2060984942 cites W2060413384 @default.
- W2060984942 cites W2062058886 @default.
- W2060984942 cites W2070896537 @default.
- W2060984942 cites W2071374363 @default.
- W2060984942 cites W2072552650 @default.
- W2060984942 cites W2076651424 @default.
- W2060984942 cites W2076826709 @default.
- W2060984942 cites W2076923050 @default.
- W2060984942 cites W2077542676 @default.
- W2060984942 cites W2077944387 @default.
- W2060984942 cites W2079982783 @default.
- W2060984942 cites W2080324970 @default.
- W2060984942 cites W2081099685 @default.
- W2060984942 cites W2084571474 @default.
- W2060984942 cites W2085801023 @default.
- W2060984942 cites W2086737677 @default.
- W2060984942 cites W2087006971 @default.
- W2060984942 cites W2088590507 @default.
- W2060984942 cites W2090372222 @default.
- W2060984942 cites W2091028264 @default.
- W2060984942 cites W2112007924 @default.
- W2060984942 cites W2112812475 @default.
- W2060984942 cites W2115448853 @default.
- W2060984942 cites W2123444403 @default.
- W2060984942 cites W2126827451 @default.
- W2060984942 cites W2126911875 @default.
- W2060984942 cites W2131500883 @default.
- W2060984942 cites W2134219151 @default.
- W2060984942 cites W2136411200 @default.
- W2060984942 cites W2138064547 @default.
- W2060984942 cites W2140885259 @default.
- W2060984942 cites W2144441170 @default.
- W2060984942 cites W2144818921 @default.
- W2060984942 cites W2145963061 @default.
- W2060984942 cites W2146502927 @default.
- W2060984942 cites W2148566884 @default.
- W2060984942 cites W2150181574 @default.
- W2060984942 cites W2152295139 @default.
- W2060984942 cites W2159782604 @default.
- W2060984942 cites W2166584384 @default.
- W2060984942 cites W2167626938 @default.
- W2060984942 cites W2325393147 @default.
- W2060984942 cites W2341184974 @default.
- W2060984942 cites W2388359100 @default.
- W2060984942 cites W4233113271 @default.
- W2060984942 doi "https://doi.org/10.1517/13543776.8.7.831" @default.
- W2060984942 hasPublicationYear "1998" @default.
- W2060984942 type Work @default.
- W2060984942 sameAs 2060984942 @default.
- W2060984942 citedByCount "2" @default.